Dr. Shailesh Kantak, assistant professor of Physical Therapy at Arcadia University, discusses the National Institute of Health (NIH) grant to study bimanual coordination in stroke recovery. Most stroke recovery practices focus on unimanual coordination in physical therapy. Dr. Kantak is studying, and developing a strategy, that uses both the strong and weak hand to regain strength and movement.
Dr. Steven Kaplan, a certified urologist at Mount Sinai in NY, discusses his new research in men with overactive bladder. He talks about the significance of the findings from the Phase 4, 12-week PLUS trial, what it means for urologists treating men with overactive bladder, the evolution of treatment during his career for patients with overactive bladder, the prominence of overactive bladder in men and why it remains an under-treated patient population despite 90 percent of men between 50-80 years’ experience lower urinary tract symptoms.
Mark Reisenauer, Senior Vice President of the oncology business unit at Astellas Oncology, who helped build the C3 (Changing Cancer Care) program talks about how he was inspired to start the program based on his experience as a caregiver for his father. The C3 Prize is open to any idea that can have an impact, especially if it’s simple.
Dr. Steve Tilles, Senior Director of Medical Affairs at Aimmune Therapeutics, a biopharmaceutical company developing treatments for life-threatening food allergies, discusses the company’s lead candidate AR101, CODIT (Characterized Oral Desensitization Immunotherapy) approach to treating food allergies and the broader food allergy landscape.
Jennifer Flynn, Healthcare Risk Manager at Aon, discusses the 2019 Healthcare Providers Service Organization’s (HPSO) Counselor Liability Claim Report which looks at the risk landscape counselors of all different types of specialties face and has important findings counselors need to be cognizant of as their profession increasingly becomes intertwined with legal proceedings.
Dr. Steven Coca discusses the product of RenalytixAI called KidneyIntelX, a diagnostic solution that uses artificial intelligence to assess the combination of predictive blood-based biomarkers and other genomic information, in combination with electronic health record information, to create a powerful model for the prediction of disease progression and drug/therapy response in individual patients at risk for CKD.
Dr. Yutaka Niihara, CEO of Emmaus Life Sciences, discusses Sickle Cell Disease in underserved minority populations and his passion for finding a treatment. Now, for the first time in 20 years there is Endari, that was FDA approved in 2017, that reduces the severe complications of Sickle Cell Disease and one that is approved for use in children five years and older.
Dr. Purvi S. Parikh, pediatric allergy and immunologist at NYU Langone Health, discusses the importance of having options for patients living in constant fear of accidental exposure to peanuts, best practices when it comes to food allergies and the potential of oral immunotherapies for that community.
Chef Tony Lawless, 59, tells his story of being diagnosed with rheumatoid arthritis at 19 to having his leg amputated. He talks about his chronic pain and finding DRG therapy (Dorsal Root Ganglion) that has helped him return to work and to inspire others with disabilities.
Dr. Eric Snyder from Geneticure discusses their recently presented data on a study utilizing their algorithm which can predict which hypertension drug would be most beneficial to patients based on their genetic makeup.